• E-mail
• Print
• RSS

False Claims Act bill moves to full House

Pharma Compliance Alert, July 23, 2008

A bill to clarify and strengthen the False Claims Act (FCA) moved out of the House Judiciary committee last week and will now be considered by the entire House of Representatives.

• Remove the requirement that false claims be presented to a government employee
• Clarify when claims filed based upon publicly disclosed information can be dismissed
• Clarify false or fraudulent claims against non-U.S. government funds under the trust and control of the U.S. government are subject to recovery under the FCA
• Clarify when a government employee may act as a qui tam relator under the FCA
• Amend the statute of limitations in FCA cases

Senator Charles Grassley (R-IA) introduced a similar bill (S 2041) in the Senate in November 2007. That bill passed out of the Senate Judiciary Committee in April.

• Comment
• E-mail to a Colleague
• Print
• RSS
• Archive

Comments